Company overview
LUMITOS is a leading B2B marketing platform serving the pharmaceutical, life sciences, laboratory, and analytical sectors since 2000. The company operates six market-leading portals and newsletters reaching over 17 million users annually, providing targeted dissemination channels for company news, product presentations, and catalogue marketing. LUMITOS helps pharmaceutical and life sciences companies connect with qualified decision-makers through specialized online portals and digital marketing services.
Lumitos is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include b2b marketing platforms, pharmaceutical portals, life sciences marketing, laboratory industry portals, analytical sector marketing.
Structured facts
- Website
- https://www.lumitos.com/en/
- Markets served
- United States & Americas
- Keywords
- b2b marketing platforms, pharmaceutical portals, life sciences marketing, laboratory industry portals, analytical sector marketing
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What industries does LUMITOS serve?
- LUMITOS serves the chemical, life science, laboratory, pharmaceutical, analytical, and food & beverage B2B markets through specialized portals and newsletters.
- How many users does LUMITOS reach?
- LUMITOS reaches over 17 million portal users annually across its six market-leading B2B portals, with more than 150,000 newsletter subscribers and 1,900 satisfied customers.
- What marketing services does LUMITOS offer?
- LUMITOS offers product presentations, catalogue presentations, company news dissemination, and targeted online marketing services designed to help B2B companies generate attention and reach new customers in their specialized sectors.
- How long has LUMITOS been operating?
- LUMITOS has been providing B2B online guidance since 2000, evolving from a university project at the Free University of Berlin in 1997 to become Europe's leading provider of specialized B2B portals and online marketing services.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
